HS Code for Retail antimalarial medicine

Retail antimalarial medicines are classified under HS code 300460. This classification follows the structure of Chapter 30, which deals with pharmaceutical products. Heading 3004 is reserved for medicaments that are prepared for retail sale or in measured doses. Subheading 300460 was specifically introduced to track and facilitate the trade of antimalarial treatments, particularly those containing active principles defined in Subheading Note 2 to Chapter 30. This note identifies specific substances such as artemisinin and its derivatives, which are critical in the global fight against malaria. The classification requires that the medicine be packaged for retail sale, meaning it is ready for use by the end consumer, often featuring labeling and dosage instructions required for pharmacy distribution. This code ensures that essential life-saving medications are monitored accurately in international trade statistics.

Products Included

• Artemisinin-based combination therapies (ACTs)
• Chloroquine phosphate tablets for retail
• Quinine sulfate capsules in retail packs
• Mefloquine hydrochloride tablets
• Artesunate injections in retail packaging

Common Misclassification

Antimalarial medicines are often misclassified under HS code 300490, which is a general "other" category for medicaments. While 300490 is a catch-all, 300460 is the specific and preferred code for antimalarials. Additionally, pure alkaloids not yet formulated into dosage forms should be classified in Chapter 29 (e.g., 2939) rather than Chapter 30.

FAQ

What is the HS code for retail antimalarial medicine?

The specific HS code for antimalarial medicaments put up for retail sale is 300460.

Does this code include bulk antimalarial ingredients?

No, bulk antimalarial medicaments not in retail packaging or measured doses are classified under HS code 300360.